Copy
Ventripoint Collaborates with Ollie Hinkle Heart Foundation to Expand Access to AI Cardiac Imaging for Children
June 26, 2026 — Toronto, Ontario — In a significant development aimed at improving cardiac care for children and adults with congenital and childhood-onset heart disease, Ventripoint Diagnostics Ltd. announced a strategic collaboration with the Ollie Hinkle Heart Foundation (OHHF). The partnership focuses on expanding access to advanced, AI-powered cardiac imaging and clinical decision-support technology, driven by a shared mission to overcome barriers faced by families dealing with heart disease.
Ventripoint, a leader in cardiac imaging innovation, has partnered with OHHF, which is renowned for its Take Heart Collective Impact Model—an initiative uniting healthcare providers, innovators, researchers, patients, families, and social partners to foster innovation and improve outcomes in pediatric heart disease care. This collaboration combines Ventripoint’s VMS+™ platform, an advanced cardiac imaging system utilizing artificial intelligence, with OHHF’s extensive network and advocacy efforts.
The VMS+™ platform provides clinicians with highly precise measurements of heart structure and function from standard echocardiogram procedures. Leveraging AI and advanced cardiac modeling, it offers detailed insights that support clinical decision-making, ongoing patient monitoring, and broadens access to sophisticated cardiac assessment tools. This technology is supported on all ultrasound systems from any vendor and holds regulatory approvals in the U.S., Europe, and Canada.
OHHF will initially support the placement of two VMS+™ units within its healthcare partner network. This financial backing aims to facilitate access to advanced cardiac imaging, advancement in education, advocacy, research, and community engagement initiatives. The collaboration is rooted in the lived experiences of families facing heart disease challenges, emphasizing the importance of timely, accurate, and affordable cardiac insights to improve health outcomes.
Joe Hostetter, Director of the Congenital Heart Disease Program at Ventripoint, highlighted the significance of the partnership: "Improving outcomes for people living with heart disease begins with access to accurate, timely, and affordable cardiac imaging. Ollie Hinkle Heart Foundation has become a respected leader in uniting families, clinicians, and innovators to address the complex challenges faced by children and their families affected by heart conditions. Together, we aim to expand access to advanced imaging solutions that enable clinicians to make more informed decisions and improve patient care throughout their journey."
The partnership reflects the foundation's deep understanding of these struggles, illustrated through personal stories from families. Katie Nesselbush, founder of Jovie's Joy and a social partner of OHHF, shared her experience as a mother of a child with dilated cardiomyopathy: "As a mother of a child living with dilated cardiomyopathy, I understand the difficult decisions families face when seeking answers about their child's heart. Technologies like Ventripoint give physicians more information to guide care while reducing barriers and risks for families. Every parent desires confidence in their decisions, and every child deserves access to the most advanced tools available."
Mark Hinkle, co-founder of OHHF, recounted the personal loss of his son Ollie at 13 months old, emphasizing the importance of technology and advocacy: "We can't change Ollie's story, nor bring Ella back, but we can honor their memories by ensuring more children access the technology, information, and treatment options they lacked. This is the future we are building with the Take Heart Collective Impact Model."
Through this collaboration, Ventripoint, OHHF, Jovie's Joy, and Ella’s Umbrella demonstrate how lived experiences and technological innovation can work together to make advanced cardiac imaging accessible to children with heart disease. The initiative aims to improve diagnostic accuracy, reduce risks, and support better health outcomes for affected families.